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Abstract
Introduction—Papillon-Lefèvre syn-
drome (PLS) is an autosomal recessive
disorder characterised by palmoplantar
keratoderma and severe,early onset perio-
dontitis, which results from deficiency of
cathepsin C activity secondary to muta-
tions in the cathepsin C gene. To date, 13
diVerent cathepsin C mutations have been
reported in PLS patients, all of which are
homozygous for a given mutation, reflect-
ing consanguinity.
Aim—To evaluate the generality of cathe-
psin C mutations in PLS, we studied an
ethnically diverse group of 20 unrelated
families.
Methods—Mutations were identified by
direct automated sequencing of genomic
DNA amplified for exonic regions and
associated splice site junctions of the
cathepsin C gene. Long range PCR was
performed to determine the genomic
structure of the cathepsin C gene.
Results—The cathepsin C gene spans over
46 kb, with six introns ranging in size from
1.6 to 22.4 kb. Eleven novel mutations and
four previously reported mutations were
identified in aVected subjects from 14
families. Missense mutations were most
common (9/15), followed by nonsense
mutations (3/15), insertions (2/15), and
deletions (1/15). Among these 14
probands, two were compound heterozy-
gotes. AVected subjects with transgres-
sions of the dermal lesions onto the knees
or elbows or both had mutations in both
the pro- and mature regions of the
enzyme, although most were in the ma-
ture region.
Conclusion—Mutations in the mature re-
gion of cathepsin C were more likely to be
associated with the transgressions of the
dermatological lesions, although the re-
sults were not statistically significant. A
comprehensive list of all cathepsin C
mutations described to date, representing
25 mutations from 32 families with PLS
and related conditions, is also presented.
(J Med Genet 2000;37:927–932)
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Papillon-Lefèvre syndrome is an inherited pal-
moplantar keratoderma (PPK) with the char-
acteristic clinical features of palmoplantar
hyperkeratosis and severe early onset periodon-
tal destruction.1 2 The palmoplantar keratoder-
mas (PPKs) are a heterogeneous group of
keratinisation disorders primarily characterised
by erythema and hyperkeratosis of the palms
and soles. More than 40 diVerent types of PPK
have been described, and based upon the clini-
cal patterning of palmoplantar dermatological
lesions these have been classified into three
general groups, diVuse, linear, or focal.3 In
many cases, the palmoplantar lesions represent
part of a wider ectodermal defect that includes
other cutaneous, mucosal, nail, hair, tooth, and
neurological abnormalities. The reclassifica-
tion of the primary PPKs proposed by Stevens
et al4 distinguished those conditions in which
the cutaneous abnormalities are restricted to
the epidermis (PPK types I, II, and III) from
those conditions that presented with a wider
ectodermal abnormality (PPK type IV). All of
those conditions in which cutaneous lesions are
restricted to the epidermis (types I, II, and III)
are either acquired or are transmitted as auto-
somal dominant traits. The Papillon-Lefèvre
syndrome (PLS) is an uncommon autosomal
recessive type IV palmoplantar ectodermal
dysplasia. In addition to the cardinal clinical
features of PPK and early onset periodontitis,
transgression of skin lesions onto the elbows,
knees, and other areas has been noted. A
number of additional clinical features have
been reported to occur with PLS, including
hearing loss, calcification of the dura, follicular
hyperkeratosis, nail abnormalities, recurrent
infections, and mental retardation.5 6 Whether
these additional clinical findings are related to
the primary genetic defect responsible for the
cardinal clinical features seen in PLS is
unknown. Patients with PLS have been shown
to have mutations in both alleles of cathepsin
C7 8 and activity of cathepsin C has been shown
to be significantly reduced in carriers of the
cathepsin C mutation, and to be virtually non-
existent in patients in whom both alleles of the
cathepsin C gene are mutated.8 PLS has been
reported to occur in a diverse range of ethnic
groups and parental consanguinity has been
noted in more than 50% of these cases.9
Cathepsin C mutations have been identified in
PLS aVected subjects from 16 families and
parental consanguinity has been reported in 14
of these.7 8 10 11 The remaining two Lebanese
families reported by Toomes et al8 are not
reported to be consanguineous; however, the
findings of shared haplotypes and homozygos-
ity of cathepsin C mutations in PLS aVected
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family members suggest that aVected members
of these families have inherited cathepsin C
mutations identical by descent from a common
ancestor. Cathepsin C mutations have also
been reported in an extended kindred with
Haim-Munk syndrome and in a kindred segre-
gating for prepubertal periodontitis without
palmoplantar keratosis.10 11 Parental consan-
guinity was noted in both these families. The
high rate of parental consanguinity observed in
PLS cases raises the possibility that the
additional clinical findings reported in some
cases of PLS may result from homozygosity at
other genetic loci and are not, in fact, related to
cathepsin C mutations.
To date, 14 diVerent mutations in the cathe-
psin C gene have been reported for PLS and
related conditions.7 8 10 11 To evaluate the gener-
ality of these cathepsin C mutations in PLS,
and to evaluate possible genotype-phenotype
correlations, we studied the cathepsin C gene
in ethnically diverse PLS aVected subjects from
20 families. Ethnic backgrounds of those stud-
ied included Bengali, Chinese, Egyptian, Ira-
nian, Panamanian, northern European, Turk-
ish, and Vietnamese (table 1).
Toomes et al8 showed that the human cathe-
psin gene is composed of seven exons, with the
exon-intron boundaries exactly matching those
of the mouse. They reported exon-intron
boundaries, but did not describe the sizes of
the specific introns. To clarify the overall
genomic structure, we used long range PCR to
determine the size of human cathepsin C
introns.
Here we describe results of our mutational
analysis, including the identification of 11
novel mutations, and also present a summary
of cathepsin C mutations identified to date in
PLS and related conditions.
Patients and methods
PATIENTS
Twenty four PLS aVected subjects, 31 parents,
and 14 unaVected sibs from 20 families were
ascertained from dental, dermatological, and
genetic clinics in Australia, England, Iran, Tur-
key, and the USA. All subjects provided
consent for the study and were clinically exam-
ined to determine the presence and location of
dermatological lesions, oral findings, and other
medical findings.
DNA EXTRACTION
Peripheral venous blood was obtained by
standard venepuncture. Genomic DNA was
isolated using the QIAamp blood kit (Qiagen
Inc).
PCR AMPLIFICATION AND SEQUENCING
Exon 1 was amplified using primer 7-1F8 as the
forward primer and 5'-CTTACCCATAACCG
AGCAGTTGAC-3' as the reverse primer.
Exons 2-6 were amplified using the primers
Table 1 Phenotype correlations with CTSC mutations reported to date
Mutation* Predicted eVect Location Phenotype†
No of
families Ethnicity Enzymatic activity‡‡ Ref
199-222del Deletion of aa 67–74 Exon 2 PLS 1 Chinese¶ 220 (parent) This report
445-446insATGT Frameshift, termination at aa 157 Exon 3 PLS 1 Bengali This report
458C→T T153I Exon 3 PLS 2 Scottish¶ 300 (parent) This report
Eqyptian
IVS3-1G→A Altered splicing Intron 3 PLS§ 1 Not specified** 8
622-623insC Frameshift, termination at aa 223 Exon 4 PLS‡ 1 Turkish 2.47 (aVected) This report
628C→T R210X Exon 4 PLS§ 1 Not specified** 8
704G→A W235X Exon 5 PLS 1 Iranian This report
745G→T V249F Exon 5 PLS§ 1 Not specified** 18.11 (aVected) 8
347.16 (parent)
748C→T R250X Exon 5 PLS‡ 1 Turkish This report
755A→T Q252L Exon 5 PLS§ 1 Not specified** 8
815G→C R272P Exon 6 PLS‡ 2 Turkish 3.67 (aVected) This report
PLS§ Not specified** 8
856C→T Q286X Exon 6 PLS‡ 2 Turkish 4.31 (aVected) 7
Turkish 10
857A→G Q286R Exon 6 HMS 1 Indian 10
898G→A G300S Exon 7 PLS 1 Vietnamese†† This report
902G→T G301V Exon 7 PLS‡ 1 Iranian This report
901G→A G301S Exon 7 PLS 2 Iranian This report
PLS§ Not specified** 8
910T→A Y304N Exon 7 PLS, RP 1 Panamanian This report
956A→G E319G Exon 7 PLS 1 Iranian This report
1015C→T R339C Exon 7 PLS 3 Egyptian This report
PLS§ Not specified** 8
PLS‡ Turkish 11
1019A→G Y340C Exon 7 PLS‡ 1 Turkish 11
1028-1029delCT Introduction of premature termination codon Exon 7 PLS‡ 1 Turkish 3.50 (aVected) 7
1040A→G Y347C Exon 7 PPP 2 Jordanian 11
PLS§ Not specified** 7.66 (aVected) 8
216.58 (parent)
1047delA Frameshift, termination at aa 349 Exon 7 PLS‡ 1 Turkish Undetectable (aVected) 7
1286G→A W429X Exon 7 PLS‡ 3 Turkish 7.32 (aVected) This report
Turkish 2.98 (aVected) 7
1360A→G E447G Exon 7 PLS 1 Vietnamese†† This report
*cDNA numbering considering the initiator Met codon as nucleotide +1. Novel mutations identified in this study are in bold.
†Phenotype symbols: PLS, Papillon-Lefevre syndrome without trangression; PLS‡, Papillon-Lefevre syndrome with trangressions of the hyperkeratotic lesions on
elbows/knees; PLS§, Papillon-Lefevre syndrome with presence or absence of trangression unknown; PPP, prepubertal periodontitis; HMS, Haim-Munk syndrome;
RP, retinitis pigmentosa.
¶Proband was a compound heterozygote for the 199-222del and 458C→T mutations.
**Families consisted of 3 Egyptian, 3 Indian/Pakistani, and 2 Lebanese.
††Proband was a compound heterozygote for the 898G→A and 1360A→G mutations.
‡‡Activity is expressed as µmol/min/mg protein.
928 Hart, Zhang, Firatli, et al
www.jmedgenet.com
described by Toomes et al.8 Exon 7 was ampli-
fied as described before (previously designated
exon 2).7 In our initial paper, the primers listed
for exon 1 were mislabelled.7 The listed
forward primer was designed to be used with a
reverse primer (5'-GGCTTAGGATTGGGG
TCTGA-3') on cDNA templates. The listed
reverse primer was designed to be used with a
forward primer (5'-GTATGCTAGAAGCGA
GAATCCGTAT-3') on genomic DNA tem-
plates. Annealing temperatures were 55°C for
exons 2 and 5, 58°C for exon 3, 60°C for exons
1 and 4, and 63°C for exons 6 and 7. PCR
products were sequenced as described previ-
ously.7
The genomic organisation of the cathepsin C
gene was determined using the primers listed
in table 2 and the Expand Long Template PCR
System (Boehringer Mannheim). BuVer 3 was
used with annealing and extension tempera-
tures of 56°C and 68°C, respectively, and an
extension time of 20 minutes. PCR products
were separated on a 0.8% agarose gel.
CATHEPSIN C ACTIVITY
Viable leucocyte pellets were obtained from
lithium heparinised whole blood by mixing
blood with three volumes of 3% dextran
(Spectrum Chemical Manufacturing Corp) in
normal saline and allowing the red cells to set-
tle for 45 minutes at room temperature. Cells
were pelleted by centrifugation at 1500 rpm for
five minutes at 4°C. After removal of the
supernatant, contaminating red cells were lysed
by adding 5 ml cold dH2O to the pellet for
exactly 45 seconds. Five ml of 1.8% saline was
then added and the mixture centrifuged at
2000 rpm for five minutes at 4°C. The white
cell pellet was washed with 5 ml cold 0.9%
saline and centrifuged at 2000 rpm for five
minutes at 4°C. Leucocyte pellets were resus-
pended in dH2O and sonicated on ice for five
seconds each for total of six blasts using a Sonic
300 Dismembrator. Protein concentration was
determined by the method of Lowry et al.12
Enzymatic activity was determined by meas-
uring hydrolysis of the synthetic substrate
glycyl-L-arginine-7-amino-4-methylcoumarin
(Bachem) at a final concentration of 5 mmol/l
using a modified method.8 All reactions were
performed in duplicate. Twenty µl of leucocyte
lysate were added to 200 µl of Na3PO4 buVer
(0.1 mol/l, pH 6.5) in a 96 well plate and then
substrate was added. Reactions were allowed to
proceed for one hour at room temperature at
which time 10 µl of glycine-NaOH buVer (0.5
mol/l, pH 9.8) was added to stop the reaction.
Fluorescence was determined using a Perkin-
Elmer LS50B luminescence spectrometer at
370 nm excitation and 460 nm emission. The
amount of NHMec released was determined
by generating a standard curve using NHMec.
Cathepsin C activity was reported as µmol
NHMec released per minute per mg protein.
GENOTYPE-PHENOTYPE ANALYSIS
The 22 probands on whom genotype and phe-
notype data were available were subdivided
into two categories for both genotype and phe-
notype. The categories for genotype were
mutations in the pro-region and mutations in
the mature enzyme. The categories for pheno-
type were the presence or absence of transgres-
sions of the hyperkeratotic lesions on the knees
and elbows. Fisher’s exact test was then
performed on the resulting 2 × 2 table. A p
value of 0.05 was considered significant.
Results
Clinically, all PLS aVected subjects presented
with PPK and severe early onset periodontitis.
In addition to palmoplantar lesions, dermato-
logical lesions were reported to extend onto the
knees and elbows in almost 60% of these
patients (table 1). Brittle fingernails were
reported in approximately 20% of aVected
subjects, but this finding was also reported to
occur in several unaVected family members
and did not appear to segregate with the PLS
phenotype. One subject was reported to have
ocular findings reminiscent of retinitis pigmen-
tosa in addition to the classical PLS findings.
Cytogenetic studies (FISH) of white blood
cells from this patient did not suggest a
chromosomal deletion that would be consistent
with a contiguous gene deletion (data not
shown). Seventeen of the 20 families were
reported to be consanguineous. The parents of
the patient with PLS and retinitis pigmentosa-
like findings were unavailable, but the identifi-
cation of a homozygous cathepsin C mutation,
and homozygosity for STRP markers flanking
the cathepsin C locus are consistent with con-
sanguinity. The parents of the two other
probands were reported to be unrelated.
Of the 20 families studied, mutations were
identified in 14, reflecting a 70% detection
rate. As shown in table 1, a total of 15
mutations were identified in these families, 11
of which were novel (fig 1). Missense mutations
were most common, accounting for 9/15
mutations detected, followed by nonsense
mutations (3/15), insertions (2/15), and dele-
tions (1/15).
All families except three were known to be
consanguineous before this study. As expected,
all 11 probands of consanguineous parents in
whom mutations were found were homozygous
for their respective mutation. The patient with
PLS and retinal changes was found to be
homozygous for a 910T→A mutation, consist-
ent with consanguinity. The two non-
consanguineous probands, both Australian,
were compound heterozygotes, one for the
199-222del and 458C→T mutations (family 1)
and the other for the 898G→A and 1360A→G
mutations (family 2). These subjects represent
Table 2 Primers used to determine genomic organisation
of cathepsin C
Region Primer sequences
Intron 1 F: 5'- TGTCAACTGCTCGGTTATGGGTAA-3'
R: 5'- TCGAGCTTCTCTTCGTACACCACT-3'
Intron 2 F: 5'- TGACTACAAGTGGTTTGCCTTTTT-3'
R: 5' TGCTGCCCTCTTCTTTATACTGC-3'
Intron 3 F: 5'- GCCTCTGAGAATGTGTATGTCAAC-3'
R: 5' CCTGCCCCAAAAATGAGATA-3'
Intron 4 F: 5' TCGAAAAATCCCAAGGTAATC-3'
R: 5' GGGCCTAGAAAGGAAATATACATT-3'
Intron 5 F: 5' AATTTGTTCGGAACTATTTATTGA-3'
R: 5' TCGCTTCTAGCATACCCATA-3'
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the first identification of compound heterozy-
gosity in PLS. Enzyme analysis of the parents
from family 1 indicated that each had approxi-
mately 50% of normal cathepsin C activity,
consistent with their carrier status. The father
and mother had specific activities of 220 and
300 µmol/min/mg, respectively (control range
685-1200 µmol/min/mg). Sequence analysis
showed that the father was the carrier of the
199-222del mutation, while the mother was
the carrier of the 458C→T mutation. Enzyme
analysis was also conducted on seven
probands, all of whom had specific activities of
less than 5% of the control range (table 1).
Within this study population, only one
mutation was found in more than one family.
The 458C→T mutation was found in two
families, one a consanguineous Egyptian family
and the other an Australian family of Scottish
ancestry.
All probands with transgression of the
dermatological lesions onto the elbows and
knees had mutations in exons 4-7, correspond-
ing to the 10 kDa pro-region and the heavy and
light chains of the mature region. There was no
correlation between the type of mutation (mis-
sense, nonsense, insertion, etc) and the pres-
ence or absence of the lesions on the knees or
elbows or both. The patients with mutations in
exons 2 and 3 have typical PLS and do not have
transgression of the lesions. Fisher’s exact test
was used to conduct a formal genotype-
phenotype analysis. A 2 × 2 table was
constructed for 22 probands. Genotypes were
classified as mutations occurring in the pro-
region of cathepsin C or in the mature enzyme,
and phenotypes were classified as the presence
or absence of transgressions of the hyperkera-
totic lesions on the elbows or knees or both. A
total of 13 patients had trangressions, with 12
of the 13 having mutations in the mature
region. Of the nine patients without trangres-
sions, five of the nine had mutations in the
mature region. The p value by Fisher’s exact
test was 0.12.
Results of long range PCR performed to
determine the genomic organisation of the
human cathepsin C gene showed that it spans
approximately 46 kb, with six introns varying in
size from 1.6 to 22.4 kb (fig 2). Our
experimental results are consistent with subse-
quently released sequence data for BAC
292e14 (Accession number AC011088).
Discussion
Cathepsin C, or dipeptidyl aminopeptidase I
(E.C. 3.4.14.1), is a lysosomal cysteine pro-
tease that removes dipeptides from the amino
terminus of protein substrates. At higher pH, it
also exhibits dipeptidyl transferase activity.13
Cathepsin C diVers from other cathepsins in
that it is an oligomeric enzyme composed of
four identical subunits.14 15 As shown in fig 2,
each subunit contains three diVerent polypep-
tide chains, the heavy chain, light chain, and
the pro-region. These chains are held together
Figure 1 Eleven novel mutations in CTSC. Mutations A-G were present in the homozygous state in aVected subjects. Mutations H and I (family 1) and
J and K (family 2) were present in the compound heterozygous state. (A) 445-446insATGT, which results in a frameshift and the introduction of a stop
codon at position 157. (B) 622-623insC, which results in a frameshift with a stop codon introduced at amino acid position 223. (C) 704G→A, which
results in W235X. (D) 748C→T, which results in R250X. (E) 902G→C, which results in G301V. (F) 910T→A, which results in Y304N. (G)
956A→G, which results in E319G. (H) 199-222del, which results in deletion of amino acids 67-74. (I) 458C→T, which results in T153I. (J) 898G→A,
which results in G300S. (K) 1360A→G, which results in E447G.
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by non-covalent interactions.16 The C-terminal
portion of the pro-region is cleaved out from
the pro-region on activation. The residual pro-
region is heterogeneous with a proportion
being intact and the remainder being cleaved at
position 58 or 61, resulting in two small
peptides held together by a disulphide bond. It
has been postulated that the pro-region is
important in the structure and activity of the
mature enzyme. The oligomerisation and pro-
tein splicing appears to occur in the endoplas-
mic reticulum-Golgi intermediate compart-
ment.17 All four potential N-glycosylation sites
are glycosylated.16
The cathepsin C gene was originally re-
ported to consist of two exons spanning 3.5
kb.18 Toomes et al8 showed that the human
cathepsin C gene is composed of seven exons,
with the exon-intron boundaries exactly
matching those of the mouse. This finding
explains the diYculty that we had amplifying
“exon 1” except from cDNA. In this report, we
show that the cathepsin C gene actually spans
over 46 kb, with the smallest intron being 1.6
kb and the largest 22.4 kb (fig 2).
Mutations in the cathepsin C gene have been
shown to result in Papillon-Lefèvre syndrome
(PLS), Haim-Munk syndrome (HMS), and
prepubertal periodontitis (PPP). The common
finding in all three conditions is severe early
onset periodontitis. The finding that the same
mutation, 1040A→G, results in two distinct
phenotypes, PLS or PPP, indicates that other
factors, genetic or environmental, play a role in
the ultimate phenotype. Clinical findings re-
ported for families with HMS vary from classi-
cal findings in PLS to PPK, severe early onset
periodontitis, onychogryposis, pes planus,
arachnodactyly, and acro-osteolysis. While the
same cathepsin C mutation (exon 6,
2127A→G) is reported in all HMS patients,
the clinical phenotype is reported to vary in
diVerent nuclear families from the same
kindred.19 20 These findings suggest that other
genetic/environmental factors may be impor-
tant determinants of the clinical phenotype
observed. To date, a total of 25 mutations have
been described in the cathepsin C gene, with
single base changes accounting for 80%
(20/25) of mutations. All of the missense
mutations, except for T153I, occur at highly
conserved residues. The T153I mutation
occurs at a residue conserved between humans
and dogs and is in the portion of the pro-region
that is normally cleaved out upon activa-
tion.17 21 Given that the T153I mutation occurs
within 10 amino acids of the N-terminal cleav-
age site, it is attractive to hypothesise that the
mutation interferes with or prevents this
normal processing. Seven mutations have been
found in more than one family (table 1). Muta-
tions 1015C→T and 1286G→A have each
been observed in three families. Although the
856C→T mutation has been described in two
Turkish kindreds, aVected members of these
families do not share a common haplotype for
genetic loci flanking the CTSC gene, suggesting
that the mutations have arisen independently.
The only distinguishing feature between the
subjects with PLS was the presence or absence
of dermatological lesions on the knees/elbows.
There was no correlation between the type of
mutation (missense, insertion, etc) and the
presence or absence of trangression of the
lesions. Although 77% (17/22) of the muta-
tions identified in our laboratory occurred in
the mature region, 92% (12/13) of the
mutations associated with transgression oc-
curred in this region compared to 56% (5/9) of
the mutations not associated with transgres-
sions. Analysis of the location of mutation
(pro-region versus mature region) by Fisher’s
exact test suggests that mutations in the mature
region are more likely to be associated with
transgression of the lesions, although the
results were not statistically significant
(p=0.12). As the underlying mutation is
discovered in additional PLS patients, further
evaluation of the genotype-phenotype correla-
tion will be possible.
One patient had PLS and eye findings
suggestive of retinitis pigmentosa. No other
Figure 2 Mutations of the CTSC gene. (A) Genomic structure of the CTSC gene with introns shown as solid lines and
exons depicted as boxes. The 5' and 3' untranslated regions are shown as filled boxes. (B) Coding region of the CTSC gene.
The amino acid numbers are shown at the end of each exon. Mutations listed in table 1 are shown according to their
genomic locations.The splicing site mutation is indicated by an arrow. (C) Subunit structure of CTSC polypeptide with SP,
signal peptide; P1, 13.5 kDa pro-region; P2, 10 kDa, pro-region; H, heavy chain; L, light chain. The 10 kDa pro-region is
cleaved out upon activation. The disulphide bond within the 13.5 pro-region is shown. The glycosylation sites are indicated
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PLS patients were reported to have eye
changes. That the subject with ocular findings
is homozygous for the 910T→A mutation sup-
ports the notion of consanguinity in this child.
The probability of manifesting a recessive
disorder is increased in consanguineous mat-
ings owing to the sharing of alleles identical by
descent. Given these findings, we hypothesise
that the retinitis pigmentosa in this proband is
probably autosomal recessive in nature and is
most likely unrelated to the cathepsin C muta-
tion.
Of the 36 families with PLS that have been
studied to date, mutations have been found in
30 families, providing a detection rate of
approximately 83%. The six families in whom
we did not find a mutation are consanguineous,
making it unlikely that a heterozygous change
was missed. Additionally, four of these families
were part of a linkage study that localised the
PLS gene to chromosome 11q14, within a can-
didate interval of less than 5 cM.22 None of
these families provided any evidence for
genetic heterogeneity, and all were consistent
with linkage to this genetic interval on
chromosome 11q. Although the possibility of
genetic heterogeneity cannot be excluded, it is
possible that intronic or regulatory mutations
of the cathepsin C gene may account for the
phenotype in these six families. Of the 25
cathepsin C mutations identified, most cluster
in the portion of the gene coding for the heavy
chain region of cathepsin C (exons 5, 6, and 7).
However, the presence of mutations in exons 2,
3, and 4 suggest that mutational analyses of the
cathepsin C gene will require evaluation of the
whole gene. Future studies will also indicate
whether or not mutations in the mature region
of the enzyme are more likely to be associated
with trangressions of the dermatological le-
sions onto the elbows/knees.
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